Skip to primary navigation
Skip to main content
Yamo Pharmaceuticals
Cutting Edge Pharmaceutial Technologies
Technology
Yamo’s Treatment for Autism
About Autism
Information for Patients and Caregivers
Future Clinical Studies
Compassionate Use Policy
Company
Overview
Our Team
Scientific Advisory Board
News & Publications
Contact Us
General Inquiries
Participation in Future Clinical Studies
News & Events
·
April 17, 2018
Safety of L1-79 in Autism
https://clinicaltrials.gov/ct2/show/NCT02947048
admin
